Xilio Therapeutics (XLO) Receivables (2024)
Xilio Therapeutics (XLO) posted Receivables of $30.0 million for Q1 2024.
Xilio Therapeutics (XLO) Receivables (2024) Analysis & Trends
Xilio Therapeutics has reported Receivables for 1 years, with the latest figure at $30.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.79 Bn | 130.93 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 56.04 Bn | 50.91 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.05 Bn | 36.95 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.71 Bn | 28.40 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 27.66 Bn | 9.26 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | - |
| 10 | Xilio Therapeutics | 178.33 Mn | 42.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 30.00 Mn |